Journal of Clinical Endocrinology & Metabolism, Vol 77, 1028-1032, Copyright © 1993 by Endocrine Society

ARTICLES

Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception

NR Young, HW Baker, G Liu and E Seeman
University of Melbourne, Department of Endocrinology, Austin Hospital, Victoria, Australia.

To determine the effect of androgens on body composition and muscle strength, we measured fat-free mass (kg), fat mass (kg), and bone density (g/cm2) by dual x-ray absorptiometry, and muscle strength (Newton meters) by dynamometry in a controlled, prospective study involving 13 nonathletic men receiving testosterone enanthate 200 mg/week in for 6 months and 8 healthy controls. Biochemical markers of bone turnover were measured in the treated subjects at baseline and 6 months. In the treated subjects at 6 months, fat-free mass (mean +/- SEM) increased by 9.6 +/- 1.0% (P < or = 0.01) whereas fat mass decreased by 16.2 +/- 6.7% (P < or = 0.05). Changes in muscle strength ranged from -1.6-19.2%. Only hip adduction increased 19.2 +/- 9.5% (P < 0.05). Changes in bone density ranged from -1.3-5.2%, decreasing significantly at one site and increasing significantly at four of the nine sites measured (P < 0.05). Serum testosterone increased by 91.1 +/- 7.5% (P < 0.01), and testicular volume decreased by 24.0 +/- 3.2% (P < 0.01). Serum osteocalcin increased by 35.7 +/- 17.3% (P < 0.05), serum immunoreactive PTH (iPTH) increased by 41.4 +/- 15.1% (P < 0.05), serum calcium decreased by 2.3 +/- 1.0% (P < 0.05), and serum albumin decreased by 4.5 +/- 1.7% (P < 0.05). There were no detectable changes in fat-free mass, fat mass, muscle strength, or bone density in controls. The administration of testosterone enanthate in pharmacological doses for 6 months resulted in a modest reduction in fat mass and small increases in fat-free mass, muscle strength, and bone density. These changes do not support the use of androgens for enhancing athletic performance.

This article has been cited by other articles:

				J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF]

				S. Bhasin Testosterone Supplementation for Aging-Associated Sarcopenia J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2003; 58(11): M1002 - 1008. [Abstract] [Full Text] [PDF]

				T. A. Roy, M. R. Blackman, S. M. Harman, J. D. Tobin, M. Schrager, and E. J. Metter Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E284 - E294. [Abstract] [Full Text] [PDF]

				P. Y. Liu, S. M. Wishart, and D. J. Handelsman A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Recombinant Human Chorionic Gonadotropin on Muscle Strength and Physical Function and Activity in Older Men with Partial Age-Related Androgen Deficiency J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3125 - 3135. [Abstract] [Full Text] [PDF]

				I. Sinha-Hikim, J. Artaza, L. Woodhouse, N. Gonzalez-Cadavid, A. B. Singh, M. I. Lee, T. W. Storer, R. Casaburi, R. Shen, and S. Bhasin Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E154 - E164. [Abstract] [Full Text] [PDF]

				D. Kinniburgh, H. Zhu, L. Cheng, A.T. Kicman, D.T. Baird, and R.A. Anderson Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men Hum. Reprod., June 1, 2002; 17(6): 1490 - 1501. [Abstract] [Full Text] [PDF]

				H. K. Kamel Testosterone and Resistance Training in AIDS Ann Intern Med, July 3, 2001; 135(1): 64 - 65. [Full Text] [PDF]

				A. Vermeulen Androgen Replacement Therapy in the Aging Male--A Critical Evaluation J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2380 - 2390. [Full Text] [PDF]

				A. M. Kenny, K. M. Prestwood, C. A. Gruman, K. M. Marcello, and L. G. Raisz Effects of Transdermal Testosterone on Bone and Muscle in Older Men With Low Bioavailable Testosterone Levels J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2001; 56(5): 266M - 272. [Abstract] [Full Text]

				S. Bhasin and M. Javanbakht Can Androgen Therapy Replete Lean Body Mass and Improve Muscle Function in Wasting Associated With Human Immunodeficiency Virus Infection? JPEN J Parenter Enteral Nutr, November 1, 1999; 23(6_suppl): S195 - S201. [Abstract] [PDF]

				L. A. Jahn, E. J. Barrett, M. L. Genco, L. Wei, T. A. Spraggins, and D. A. Fryburg Tissue Composition Affects Measures of Postabsorptive Human Skeletal Muscle Metabolism: Comparison across Genders J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1007 - 1010. [Abstract] [Full Text]

				S. Bhasin VIII. Conclusion--Research Design Issues in Examining the Effects of Testosterone Supplementation in Older Men J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3445 - 3448. [Full Text]

				V. Luukkaa, U. Pesonen, I. Huhtaniemi, A. Lehtonen, R. Tilvis, J. Tuomilehto, M. Koulu, and R. Huupponen Inverse Correlation between Serum Testosterone and Leptin in Men J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3243 - 3246. [Abstract] [Full Text]

				S. Arslanian and C. Suprasongsin Testosterone Treatment in Adolescents with Delayed Puberty: Changes in Body Composition, Protein, Fat, and Glucose Metabolism J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3213 - 3220. [Abstract] [Full Text] [PDF]

				F. Jockenhovel, W. F. Blum, E. Vogel, P. Englaro, D. Muller-Wieland, D. Reinwein, W. Rascher, and W. Krone Testosterone Substitution Normalizes Elevated Serum Leptin Levels in Hypogonadal Men J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2510 - 2513. [Abstract] [Full Text] [PDF]

				S. Bhasin, T. W. Storer, N. Berman, K. E. Yarasheski, B. Clevenger, J. Phillips, W. P. Lee, T. J. Bunnell, and R. Casaburi Testosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 407 - 413. [Abstract] [Full Text] [PDF]

				C.-Y. Guo, T. H. Jones, and R. Eastell Treatment of Isolated Hypogonadotropic Hypogonadism Effect on Bone Mineral Density and Bone Turnover J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 658 - 665. [Abstract] [Full Text] [PDF]

				I. R. Reid, D. J. Wattie, M. C. Evans, and J. P. Stapleton Testosterone Therapy in Glucocorticoid-Treated Men Arch Intern Med, June 10, 1996; 156(11): 1173 - 1177. [Abstract] [PDF]

				C. J. Bagatell and W. J. Bremner Androgens in Men -- Uses and Abuses N. Engl. J. Med., March 14, 1996; 334(11): 707 - 715. [Full Text] [PDF]